Literature DB >> 21039361

Symptoms and side effects in chronic non-cancer pain: patient report vs. systematic assessment.

T Jonsson1, L L Christrup, J Højsted, H H Villesen, T H Albjerg, L V Ravn-Nielsen, P Sjøgren.   

Abstract

BACKGROUND: relieving distressing symptoms and managing the side effects of analgesics are essential in order to improve quality of life and functional capacity in chronic non-cancer pain patients. A quick, reliable and valid tool for assessing symptoms and side effects is needed in order to optimize treatment. We aimed to investigate the symptoms reported by chronic non-cancer pain patients after open-ended questioning vs. a systematic assessment using a list of symptoms, and to assess whether the patients could distinguish between the symptoms and the side effects induced by analgesics.
METHODS: patients treated with either opioids and/or adjuvant analgesics were asked to report their symptoms spontaneously, followed by a 41-item investigator-developed symptom checklist. A control group also filled in the checklist.
RESULTS: a total of 62 patients and 64 controls participated in the study. The numbers of symptoms reported by the patients (9.9 ± 5.9) were significantly higher than those reported by the controls (3.2 ± 3.9) (P<0.001). In the patient group, the number of spontaneously reported symptoms (1.3 ± 1.4) was significantly lower than the symptoms reported when using the symptom checklist (9.9 ± 5.9) (P<0.001). The six most frequently symptoms reported by the patients were: (1) Fatigue; (2) Memory deficits; (3) Dry mouth; (4) Concentration deficits; (5) Sweating; and (6) Weight gain. Out of the six most frequently reported symptoms, the share of side effects due to analgesics was: (1) Dry mouth (42%); (2) Sweating (34%); (3) Weight gain (29%); (4) Memory deficits (24%); (5) Fatigue (19%); and (6) Concentration deficits (19%).
CONCLUSION: the number of symptoms reported using systematic assessment was eightfold higher than those reported voluntarily. Fatigue, cognitive dysfunction, dry mouth, sweating and weight gain were the most frequently reported. The patients reported the side effects of their analgesics to contribute substantially to the reported symptoms. 2010 The Acta Anaesthesiologica Scandinavica Foundation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21039361     DOI: 10.1111/j.1399-6576.2010.02329.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  8 in total

Review 1.  Opioids and Chronic Pain: Where Is the Balance?

Authors:  Mellar P Davis; Zankhana Mehta
Journal:  Curr Oncol Rep       Date:  2016-12       Impact factor: 5.075

2.  Survey of Primary-Care Providers on Perceived Benefits of and Barriers to PainTracker.

Authors:  Melissa M Schorn; Ardith Z Doorenbos; Debra Gordon; Patricia Read-Williams
Journal:  J Nurse Pract       Date:  2014-12       Impact factor: 0.767

3.  Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.

Authors:  Erin E Krebs; Amy Gravely; Sean Nugent; Agnes C Jensen; Beth DeRonne; Elizabeth S Goldsmith; Kurt Kroenke; Matthew J Bair; Siamak Noorbaloochi
Journal:  JAMA       Date:  2018-03-06       Impact factor: 56.272

4.  Chronic pain. Decreased motivation during chronic pain requires long-term depression in the nucleus accumbens.

Authors:  Neil Schwartz; Paul Temkin; Sandra Jurado; Byung Kook Lim; Boris D Heifets; Jai S Polepalli; Robert C Malenka
Journal:  Science       Date:  2014-08-01       Impact factor: 47.728

5.  Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study.

Authors:  Cheol Kyu Park; Hyun Wook Kang; In Jae Oh; Young Chul Kim; Yeo Kyeoung Kim; Kook Joo Na; Sung Ja Ahn; Tae Ok Kim; Young Jin Choi; Geun Am Song; Min Ki Lee
Journal:  J Korean Med Sci       Date:  2016-12       Impact factor: 2.153

6.  Ultramicronized N-Palmitoylethanolamine Supplementation for Long-Lasting, Low-Dosed Morphine Antinociception.

Authors:  Lorenzo Di Cesare Mannelli; Laura Micheli; Elena Lucarini; Carla Ghelardini
Journal:  Front Pharmacol       Date:  2018-06-01       Impact factor: 5.810

7.  Predictors of Dropout in a Digital Intervention for the Prevention and Treatment of Depression in Patients With Chronic Back Pain: Secondary Analysis of Two Randomized Controlled Trials.

Authors:  Isaac Moshe; Yannik Terhorst; Sarah Paganini; Sandra Schlicker; Laura Pulkki-Råback; Harald Baumeister; Lasse B Sander; David Daniel Ebert
Journal:  J Med Internet Res       Date:  2022-08-30       Impact factor: 7.076

Review 8.  Eliciting adverse effects data from participants in clinical trials.

Authors:  Elizabeth N Allen; Clare Ir Chandler; Nyaradzo Mandimika; Cordelia Leisegang; Karen Barnes
Journal:  Cochrane Database Syst Rev       Date:  2018-01-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.